Valneva SE (VALN) Equity Income (2021)
Valneva SE (VALN) posted Equity Income of -$58.2 million for Q4 2025, down 12.13% sequentially from -$51.9 million in Q3 2025, and down 47.6% YoY from -$111.1 million in Q4 2024.
Analysis
Valneva SE (VALN) Equity Income (2021) Analysis & Trends
Valneva SE has reported Equity Income for 3 years, with the latest figure at -$58.2 million in Q4 2025.
- Quarterly Equity Income fell 47.6% year-over-year to -$58.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$159.8 million (down 221.79% YoY) and the FY2025 annual result came in at -$134.1 million, down 915.54% from the prior year.
- Equity Income slipped to -$58.2 million in Q4 2025 per VALN's latest filing, from -$51.9 million in the prior quarter.
- Over five years, Equity Income peaked at $101.7 million in Q3 2021 and troughed at -$70.7 million in Q2 2021.
- A 3-year average of -$20.2 million and a median of -$36.4 million in 2024 frame the typical range for Equity Income.
- The widest YoY moves for Equity Income: up 47.6% in 2025, down 408.21% in 2025.
- Over 3 years, Equity Income stood at $131556.7 in 2021, then sank by 30072.77% to -$39.4 million in 2024, then plunged by 47.6% to -$58.2 million in 2025.
- According to Business Quant data, Equity Income over the past three periods registered -$58.2 million, -$51.9 million, and -$39.4 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 581.90 Mn | 440.64 Mn | 1.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 131,556.66 |
| Sep 30, 2021 | -35,378.62 |
| Jun 30, 2021 | -85,503.27 |
| Mar 31, 2021 | -22,918.49 |